There could be new hope on for kidney cancer patients. Researchers announced early results of an anti-tumor vaccine for ...
A vaccine to fight cancers affecting women will be available in five to six months, and those in the age group of nine to 16 ...
All nine patients treated with a personalized cancer vaccine following removal of their tumors remained cancer-free at a median data cut-off of 34.7 months.
EPS estimates but beats revenue expectations. Barclays downgrades stock, citing COVID demand decline and RSV uptake ...
The vaccine will be administered to girls between the ages of nine and 16 as part of the government’s initiative to address the rising number of cancer cases in the country.
Merck & Co.’s first trial over the safety of its blockbuster Gardasil cancer vaccine was cut short and rescheduled amid ...
There could be new hope on the horizon for kidney cancer patients in the form of an experimental vaccine. Researchers at Dana-Farber Cancer Institute, Harvard Medical School, Yale Cancer Center ...
A new vaccine for kidney cancer shows excellent preliminary results. All patients on the trial had no evidence of cancer ...
Patients with advanced kidney cancer who received an experimental vaccine after their tumors were removed were still ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results